EcoDrugPlus

Melanocortin 4 Receptor

Ensembl ID : ENSCLAG00000017847
Gene Symbol: MC4R
2 Cross references
229 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSCLAG00000015269
Gene Symbol: MTNR1A
3 Cross references
216 Possible Orthologues:

Melatonin Receptor 1b

Ensembl ID : ENSCLAG00000012055
Gene Symbol: MTNR1B
2 Cross references
107 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSCLAG00000001839
Gene Symbol: MME
2 Cross references
236 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSCLAG00000009110
Gene Symbol: METAP2
2 Cross references
229 Possible Orthologues:

Microtubule Associated Protein Tau

Ensembl ID : ENSCLAG00000005870
Gene Symbol: MAPT
1 Cross references
226 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSCLAG00000016981
Gene Symbol: MAPK1
3 Cross references
214 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSCLAG00000007752
Gene Symbol: MAPK10
2 Cross references
222 Possible Orthologues:

Mitogen-Activated Protein Kinase 11

Ensembl ID : ENSCLAG00000017044
Gene Symbol: MAPK11
2 Cross references
201 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSCLAG00000009182
Gene Symbol: MAPK14
2 Cross references
295 Possible Orthologues:

Mitogen-Activated Protein Kinase 3

Ensembl ID : ENSCLAG00000013110
Gene Symbol: MAPK3
2 Cross references
199 Possible Orthologues:

Mitogen-Activated Protein Kinase 8

Ensembl ID : ENSCLAG00000000585
Gene Symbol: MAPK8
3 Cross references
292 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).